The market is segmented based on
世界の白皮症治療薬市場、タイプ別（眼皮膚白皮症、X連鎖眼白皮症、ヘルマンスキー・パドラック症候群、チェディアック・東症候群）、治療タイプ別（手術、薬物、その他）、流通チャネル別（オンライン薬局、直接入札、小売業者、その他）、エンドユーザー別（病院、在宅ケア、専門クリニック、その他） - 2030年までの業界動向と予測。
.
The Global Albinism Drug Market size was valued at USD 207.00 USD Million in 2022.
The Global Albinism Drug Market is projected to grow at a CAGR of 5.4% during the forecast period of 2023 to 2030.
The major players operating in the market include AbbVie Inc. , Roche Holding AG , Novartis International AG , Johnson &, Johnson , Pfizer Inc. , Merck &, Co.Inc. , Sanofi , AstraZeneca plc , GlaxoSmithKline plc , Bristol Myers Squibb Company , Eli Lilly and Company , Amgen Inc. , Gilead SciencesInc. , Takeda Pharmaceutical Company Limited , Bayer AG .
Corporate Email ID Only (Avoid Using Generic mail ID such as Gmail)
Consent Preferences
We use cookies to improve your experience We use cookies to deliver the best possible experience on our website. To learn more, visit our Privacy Policy. By continuing to use this site, or closing this box, you consent to our use of cookies. Cookie Notice.
The data presented is for visualization purposes only and may not reflect actual results.